Ofelia Mesina

Statistics

Publications

Citations

274

H-Index

Active since

1996

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Ofelia Mesina is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and non-hodgkin lymphoma treatment.

Publications per year

1996–2008

Publications

Efficacy of Dasatinib in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CML-CP)

Jörge E. Cortes, Susan O’Brien, Gautam Borthakur et al. · Blood · 2008 · 71 citations

Medicine, Oncology, Pharmacology +5

Non-Hodgkin's Lymphoma Affecting the Testis: Is It Curable with Doxorubicin-Based Therapy?

Carlo Visco, L. Jeffrey Medeiros, Ofelia Mesina et al. · Clinical Lymphoma · 2001 · 49 citations

Medicine, Oncology, Chemotherapy +8

CD20 Expression in Hodgkin and Reed-Sternberg Cells of Classical Hodgkin’s Disease: Associations With Presenting Features and Clinical Outcome

George Z. Rassidakis, L. Jeffrey Medeiros, Simonetta Viviani et al. · Journal of Clinical Oncology · 2002 · 48 citations

Medicine, Hematology, Oncology +15

Cyclosporin A does not reverse clinical resistance to paclitaxel in patients with relapsed non-Hodgkin's lymphoma.

A H Sarris, Anas Younes, Peter McLaughlin et al. · Journal of Clinical Oncology · 1996 · 38 citations

Medicine, Pharmacology, Pharmacotherapy +15

Trimetrexate in Relapsed T-Cell Lymphoma With Skin Involvement

A H Sarris, Alexandria T. Phan, Madeleine Duvic et al. · Journal of Clinical Oncology · 2002 · 31 citations

Medicine, Pharmacology, Pharmacotherapy +12

1–5 of 8